Minderoo Foundation

Proximie Inc., based in Bedford, Massachusetts, offers a secure software platform that facilitates virtual surgical collaboration among surgeons. By leveraging advanced telecommunication, augmented reality, artificial intelligence, and machine learning technologies, Proximie's platform enables real-time, peer-to-peer assistance during surgeries, regardless of location. This innovative approach allows surgeons to share expertise before, during, and after procedures, effectively overcoming the barriers of time and distance. Furthermore, the platform is compatible with various devices and software used in operating rooms, allowing for seamless integration and interaction. Proximie's mission is to enhance surgical knowledge and skills, enabling surgeons to refine their techniques in diverse settings, even with limited bandwidth.

Her Black Book is a curated Shopping & Discovery App, for women who love to shop. The chic platform enables shoppers to browse for their favourite brands, discover new products, great deals, and promos via discounts and Cashback features. HBB provides retailers a premium incentive destination that aligns with their brand's style and values and offers a digital magazine of styling tips and engaging content across fashion, beauty, lifestyle, and business.

Getlabs, Inc. is a digital health company based in Santa Monica, California, founded in 2018. The company has developed a platform that simplifies the process of scheduling home lab appointments, enabling medical professionals to visit patients for diagnostic tests. This approach alleviates the stress of traditional lab visits by eliminating the need for patients to wait in clinical settings. Getlabs facilitates the collection of samples, which are then delivered to laboratories for processing, thus enhancing the efficiency of healthcare delivery. By focusing on improving the patient experience, the company aims to create a seamless connection between virtual and in-person care. Its mission is to make lab testing convenient and comfortable for patients, while also supporting healthcare providers and laboratories in achieving better outcomes and timely diagnoses.

Mr. Green Africa Ltd is a Nairobi-based company founded in 2014 that focuses on plastic recycling and waste management. The company aims to transform perceptions of waste into value by addressing social and environmental challenges through a sustainable business model. It specializes in the collection, conversion, and sale of post-consumer plastic waste, offering a variety of recycled materials, including rHDPE, rPP, and rPET pellets in multiple colors. Mr. Green Africa integrates informal waste workers and micro-entrepreneurs into a formal value chain, promoting economic growth while minimizing environmental impact. By providing pre-processed recycling materials with a traceable social and environmental impact, the company contributes to reducing the negative effects of plastic packaging on the environment.

Inrupt, Inc. operates an open-source platform aimed at decentralizing the web through a series of modular specifications. The core offering, Solid, empowers users and organizations to separate their data from the applications that utilize it, allowing for greater control over personal information. This platform facilitates the creation, management, and security of personal online data stores, enabling clients to use their data across multiple applications simultaneously. Inrupt serves a diverse audience, including developers, organizations, and individual users. Founded in 2017 and headquartered in Boston, Massachusetts, Inrupt is committed to transforming how personal data is handled online.

Ena Respiratory is a biotechnology company based in Melbourne, Australia, founded in 2014. The company focuses on developing innovative solutions for the treatment and prevention of respiratory infections. Ena Respiratory specializes in synthetic Toll-like receptor 2 (TLR2) agonists, which are designed to activate the innate immune system in the respiratory tract. This activation helps to prevent both viral and secondary bacterial infections in the lungs. In addition to its therapeutic innovations, the company also evaluates the effectiveness of vaccines.

Ena Respiratory is a biotechnology company based in Melbourne, Australia, founded in 2014. The company focuses on developing innovative solutions for the treatment and prevention of respiratory infections. Ena Respiratory specializes in synthetic Toll-like receptor 2 (TLR2) agonists, which are designed to activate the innate immune system in the respiratory tract. This activation helps to prevent both viral and secondary bacterial infections in the lungs. In addition to its therapeutic innovations, the company also evaluates the effectiveness of vaccines.